Here is What Hedge Funds Think About Alnylam Pharmaceuticals, Inc. (ALNY)
"Market conditions are changing.
Posts Tagged ‘NASDAQ:ALNY’
Hedge Funds Are Dumping Alnylam Pharmaceuticals, Inc. (ALNY)
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Market Movers Today: Alnylam Pharmaceuticals, Inc. (ALNY), Snap Inc (SNAP), Sellas Life Sciences Group Inc (SLS), Intel Corporation (INTC), and More
What happened: Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), a precommercial pioneer of RNA-based therapies, continued a slide that began just ahead of the weekend.
32 Major Stories Summarizing What’s Happening in the World of Finance Today
"The S&P 500 and the Nasdaq Composite hit fresh intraday records on Monday as a jump in oil prices to a two-week high lifted Wall Street sentiment.
5 Stocks The Best Performing Hedge Funds Are Piling Into
At Insider Monkey, we track more than 700 of the best hedge funds in the world and have developed various market-beating strategies over the years using the wealth of data we ...
Is Alnylam Pharmaceuticals, Inc. (ALNY) A Good Stock To Buy Right Now?
The worries about the election and the ongoing uncertainty about the path of interest-rate increases have been keeping investors on the sidelines.
SYNNEX, Hibbett Sports, and Alnylam Among 5 Stocks With Notable Insider Trading
U.S indexes have opened lower this morning, as the trading week has kicked off with a plunge in global bonds courtesy of inflation fears.
Here’s What Happened With Alnylam Pharmaceuticals, Inc. (ALNY) and Tenax Therapeutics Inc (TENX)
A couple of companies have had a tough twenty-four hours in the biotech space.
Why Yum, Booz Allen Hamilton, Alnylam, and More Are in the Spotlight
Many traders are watching crude futures today to see if WTI can break out of the $50 per barrel mark.
Alnylam Pharmaceuticals, Inc. (ALNY): Eastern Capital Owns 3.8 Million Shares
Given the volatile nature of the markets, investors should pay attention to the latest moves made by elite hedge funds and other investors in their conviction picks, to get a ...
Hedge Funds Aren’t Crazy About Alnylam Pharmaceuticals, Inc. (ALNY) Anymore
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing...
The Medicines Company (MDCO) and Alnylam Pharmaceuticals Inc. (ALNY)’s Positive Phase I Results Support Hedge Funds’ Confidence in These Companies
On August 30, The Medicines Company (NASDAQ:MDCO) and Alnylam Pharmaceuticals Inc.
Bridger Management’s Top Picks
Bridger Management, led by Roberto Mignone, has filed its 13F with the SEC for the current reporting period.
5 Mid-Cap Stocks That Insiders Love
Recent research conducted at InsiderMonkey has shown that stocks bought by insiders tend to outperform market indexes.
Three Stocks That Have Wittnessed Millionaire Insider Purchases Lately
Tracking insider purchases can provide an investor with great ideas, just like keeping an eye on hedge fund moves.
Biogen Idec Inc (BIIB), ISIS Pharmaceuticals, Inc. (ISIS), Alnylam Pharmaceuticals, Inc. (ALNY): A Ringing Endorsement of a Technology Years in the Making
For the latest deal, Biogen Idec Inc (NASDAQ:BIIB) is giving Isis $100 million up front, and ISIS Pharmaceuticals, Inc.
Universal Health Services, Inc. (UHS), Alnylam Pharmaceuticals, Inc. (ALNY), Alere Inc (ALR): Health Care Companies Built for Growth
The health care sector has been one of the best performing sectors of 2013.
Alnylam Pharmaceuticals, Inc. (ALNY) & Conferences, Synta Pharmaceuticals Corp. (SNTA)’s Investors, Inovio Pharmaceuticals Inc (INO)’s Vaccinations
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that management will present a company overview at the Morgan Stanley Global Healthcare Conference...
Viropharma Inc (VPHM): Are Hedge Funds Right About This Stock?
If you were to ask many traders, hedge funds are seen as useless, old investment vehicles of an era lost to time.
Hedge Funds Are Selling Arena Pharmaceuticals, Inc. (ARNA)
Now, according to many market players, hedge funds are viewed as delayed, outdated financial tools of an era lost to time.
Alnylam Pharmaceuticals, Inc. (ALNY): Insiders Aren’t Crazy About It But Hedge Funds Love It
If you were to ask many market players, hedge funds are seen as useless, outdated financial tools of a period lost to current times.
Pfizer Inc. (PFE), Regeneron Pharmaceuticals Inc (REGN): Are These Drugs the Future of High-Cholesterol Treatment?
Once upon a time in a regulatory environment far, far away, there was a cholesterol-fighting drug named Lipitor from Pfizer Inc. (NYSE:PFE).
Arena Pharmaceuticals, Inc. (ARNA): What Do The Smartest Investors Think?
In the financial world, there are tons of indicators investors can use to watch their holdings. Some of the most under-the-radar are hedge fund and insider trading sentiment.
Alnylam Pharmaceuticals, Inc. (ALNY): Here’s What The Smart Money Thinks
Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) the right investment to pursue these days? Hedge funds are taking a bullish view.
Alexion Pharmaceuticals, Inc. (ALXN), Onyx Pharmaceuticals, Inc. (ONXX): Will This Orphan Drug Maker Find a New Home?
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), already quite expensive, spiked higher since takeover rumors surfaced in early July.
Inovio Pharmaceuticals Inc (INO), Alnylam Pharmaceuticals, Inc. (ALNY): This Company Is in a Perfect Position to Take-off
In 2013, a number of new drugs got approvals from the FDA. This provided a boost to the biotech industry as a whole.
Amgen, Inc. (AMGN)’s Acquisition Ambition Leads Biotechs’ Rise
Biotech's the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling up or down by significant amounts...
ACADIA Pharmaceuticals Inc. (ACAD), Alnylam Pharmaceuticals, Inc. (ALNY) & Celldex Therapeutics, Inc. (CLDX): Buy These Biotech Companies for Long-Term Growth
According to IBISWorld, revenue of global biotechnology companies will surge to $262 billion this year, up by 12.7%, year-over-year.
Prosensa Holding BV (RNA), WebMD Health Corp. (WBMD): Three Humongous Health-Care Stocks This Week
If you thought the fireworks ended after the Fourth of July celebrations last week, think again.
Alnylam Pharmaceuticals, Inc. (ALNY)’s Surge Caps Off a Strong Week in Biotech
Biotech's the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling up or down by significant amounts...
Inovio Pharmaceuticals Inc (INO), Alnylam Pharmaceuticals, Inc. (ALNY): This Week in Biotech
With the SPDR S&P Biotech Index up 33% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Alnylam Pharmaceuticals, Inc. (ALNY), ISIS Pharmaceuticals, Inc. (ISIS), Merck & Co., Inc. (MRK): RNAi Companies to Consider
RNAi and RNA companies had a terrible time when they were abandoned by big pharmaceutical companies.
Onyx Pharmaceuticals, Inc. (ONXX), Achillion Pharmaceuticals, Inc. (ACHN): This Week in Biotech
With the SPDR S&P Biotech Index up 20% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Onyx Pharmaceuticals, Inc. (ONXX), Celldex Therapeutics, Inc. (CLDX): Three Humongous Health-Care Stocks This Week
While many American skies were lit up with fireworks this week, the stock market also saw its share of pops, sizzles, and bangs.
Synageva BioPharma Corp (GEVA): Hedge Funds and Insiders Are Bullish, What Should You Do?
In the 21st century investor’s toolkit, there are tons of indicators investors can use to track stocks. Some of the most useful are hedge fund and insider trading activity.
Pipeline Probe: Alnylam Pharmaceuticals, Inc. (ALNY)
Shares of biotech Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) have soared over 160% in the past year.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE): Top Treatments for High Cholesterol
About a third of American adults have high LDL cholesterol -- that's the bad kind -- but less than half of adults with high LDL seek treatment, according to the Centers for Disease...
Do Hedge Funds and Insiders Love Alnylam Pharmaceuticals, Inc. (ALNY)?
To most traders, hedge funds are assumed to be unimportant, old investment vehicles of years past.
Arena Pharmaceuticals, Inc. (ARNA): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) was in 13 hedge funds' portfolio at the end of the first quarter of 2013.
Arena Pharmaceuticals, Inc. (ARNA): The Mind-Blowing Data You Missed
Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) a healthy stock for your portfolio? Money managers are taking a bullish view.
Idenix Pharmaceuticals Inc (IDIX), Alnylam Pharmaceuticals, Inc. (ALNY) & 3 Small Biotechs Top Hedge Funds Are Investing In
Small biotech companies have great investment potential if you can identify them properly.
Hedge Funds Are Betting On Alnylam Pharmaceuticals, Inc. (ALNY): Arena Pharmaceuticals, Inc. (ARNA), Acorda Therapeutics Inc (ACOR)
Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) a first-rate stock to buy now? Investors who are in the know are turning bullish.
Opko Health Inc.(OPK)’s Massive Insider Buys: Should Investors Follow Suit? – Alnylam Pharmaceuticals, Inc. (ALNY), Merck & Co., Inc. (MRK)
"There are many reasons for an insider to sell a stock, but only one to buy it: he expects to make money." So goes the saying.
Three Stocks For The Long Haul: NetEase, Inc (ADR) (NTES), Tenet Healthcare Corp (THC), ISIS Pharmaceuticals, Inc (ISIS)
I have reviewed over 80 stocks as investment opportunities.
